NOVASEP est membre de Lyonbiopôle

General information

39 Saint-Jean-de-Dieu

69007 Lyon

Incorporated in: 1996/01/01

Number of employees: 1200

Turnover: €267M (in 2015)


Main activity

Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. Our unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients as well as fermentation and chemical commodities industries.  Novasep's excellent regulatory inspection history was further confirmed with all five manufacturing sites having successfully undergone Pre-Approval Inspections (PAIs) by the FDA over the last three years.  With 1,200 employees, Novasep is established in Europe, Asia and North America and is constantly expanding its presence to better serve its customers.  Further expansion is planned with a €10 m investment in an ADC conjugation facility at the existing site in Le Mans, France which was announced in June 2015.  We aim to be a highly respected, top tier service provider in all our market segments through the passion of our people and the excellence of our processes.  


Looking for funding: Yes

Nature of funding searches:

Looking for collaborative R&D projects and associated funding.  

Products / Services / Technologies

Strategic area of application
Human Medicine

Application market
Cardiology - Oncology

CMO - Technology provider

Chemical synthesis services & medicinale chemistry - Vaccine - Antibodies - Protein - Peptide

En poursuivant votre navigation sur ce site, vous acceptez l'utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d'intérêt. En savoir plus... Fermer